Super infections are more common, but drugs aren't being developed...

Tweet

I feel that we are reaching the end of the road with the antibiotics needed to figh the Superbugs running rampant in our world today. It is unfortunate that it takes so many millions of dollars for a company to develop, test, and get approval for a new drug. The process can take up to 10 years before being released on the market. By that time, the company has spent so much that they need to see a return on this huge investment. So unfortunatly, many companies are turning to drugs that will be more widely used, such as blood pressure medication, diabetes and other heart medication, or anti depressants. These investments are a sure thing, and the company will see a return on their investment. But to develope an antibiotic, that's a whole other ball park. Those are hard to develope. Bugs mutate, they turn resistant, and (for now) the need for these heavy duty drugs isn't as common as diabetic medication is. So why would a company spend so much time, money, and resoarces on such a shaky investemnt? WEll, not many are so willing to do that anymore. With how long it takes to get a drug developed and approved, it runs the risk of being obsolete once it hits the market. And since it's basically poison, they have to try to keep side effects down while trying to make it as effective as possible. Then once the bugs become resistant, it won't be used any longer. Who can blam drug companies for not wanting to develope these types of drugs? So we are stuck in a catch 22. The companies don't want to waste their time on a dead end road because of the little return after the immense expense, and yet we are running out of options for the heavy duty drugs left to fight these Superbugs we have. Will we run completely out of options in our near future? Does this seem scary to anyone else??